Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

13

Number of overlapping holdings

44.8%

% of PBE's 29 holdings also in FBT

43.3%

% of FBT's 31 holdings also in PBE

Overlap by Weight
Sector Drift (PBE minus FBT)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in PBE
Weight
in FBT
Overlap
BIOMARIN PHARMACEUTICAL INC 5.3% 3.6% 3.6%
UNITED THERAPEUTICS CORP 5.4% 3.4% 3.4%
REGENERON PHARMACEUTICALS 5.1% 3.3% 3.3%
VERTEX PHARMACEUTICALS INC 5.4% 3.2% 3.2%
GILEAD SCIENCES INC 5.3% 3.2% 3.2%

Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to FBT
VERICEL CORPORATION 3.2%
INTRA-CELLULAR THERAPIES INC 3.1%
ARROWHEAD PHARMACEUTICALS, INC. 3.0%
MYRIAD GENETICS INC 3.0%
VERACYTE INC 3.0%
REPLIGEN CORP 2.9%
CATALYST PHARMACEUTICAL PART 2.8%
HALOZYME THERAPEUTICS INC 2.8%
DYNAVAX TECHNOLOGIES CORP 2.7%
OPKO HEALTH INC 2.6%
PBE Underweight Relative to FBT
GRIFOLS SA-ADR -3.9%
ULTRAGENYX PHARMACEUTICAL IN -3.8%
IQVIA HOLDINGS INC -3.7%
BIONTECH SE SPONSORED ADR -3.6%
IONIS PHARMACEUTICALS, INC. -3.5%
GENMAB A/S SPONSORED ADR -3.5%
METTLER-TOLEDO INTERNATIONAL -3.5%
CHARLES RIVER LABORATORIES -3.5%
ARGENX SE ADR -3.4%
AGIOS PHARMACEUTICALS INC -3.4%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY